MARLBOROUGH, Mass., April 24, 2024 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a reported
MARLBOROUGH, Mass., April 24, 2024 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a reported
Wells Fargo analyst Larry Biegelsen maintained a Hold rating on Axonics Modulation Technologies (AXNX – Research Report) today and set a price target of $71.00. The company’s shares opened today
In a report released on April 15, Shagun Singh Chadha from RBC Capital maintained a Hold rating on Axonics Modulation Technologies (AXNX – Research Report), with a price target of
In a report released on April 8, Shagun Singh Chadha from RBC Capital maintained a Hold rating on Axonics Modulation Technologies (AXNX – Research Report), with a price target of
Axonics (AXNX) announced that its stockholders have voted to adopt Axonics’ merger agreement with Boston Scientific (BSX). The closing of the transaction is expected to occur in the first half